The CARE (Collaborative Adolescent Running Experience) Project

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05837351
Collaborator
(none)
40
1
1
24
1.7

Study Details

Study Description

Brief Summary

This study is being completed to see if participants activity levels may have an impact as a treatment for depression, or depressive symptoms.

Eligible participants will be enrolled and have an 8-week running intervention three times each week.

The study hypothesizes that adolescents with Psychiatric disorders that are experiencing depressive symptoms will participate in a supported running intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise -Running
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The CARE Project: Collaborative Adolescent Running Experience
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise -Running

Behavioral: Exercise -Running
At baseline participants will wear a Fitbit for one week and attend the Runner's Assessment. After this the participant will begin to run 3 times per week for eight weeks. Every week, participation in a virtual support group with the physical therapist, research coordinator, and other research staff will be expected. Rest-activity cycles' data will be monitored; if at any point the runner is not able to complete 3 runs per week, participants will be encouraged to contact research staff the issues for this (such as medical problem or scheduling difficulty) and formulate plans to remediate the situation. Participants that would like to continue the treatment for an additional eight weeks will have additional data collected. Participants will also wear the Fitbit through-out the study and complete surveys during the study and have blood drawn.

Outcome Measures

Primary Outcome Measures

  1. The number of completed running sessions [weeks 1-8 during treatment period]

    Feasibility and acceptability of the study will be the completion of running sessions based on the Fitbit and or self-report.

Secondary Outcome Measures

  1. Change in depression severity as reported by The Patient Health Questionnaire for Adolescents (PHQ-A) [Baseline (prior to treatment), 8 weeks (post intervention)]

    This is a self-report questionnaire designed for the purpose of assessing anxiety, mood, eating, and substance use disorders. For the first section (9 questions) the participants will select from Not at all (0) to nearly every day (3). The next section asks if in the past year participants felt depressed or sad most days (yes or no) and if so, not difficult at all to extremely difficult. The last question participants are asked about suicide. Scores of 5, 10, 15, and 20 represent cut points for mild, moderate, moderately severe and severe depression.

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Psychiatric disorders that are experiencing depressive symptoms (defined by the protocol)

  • Must have a smart phone

  • Parents/guardians will be advised to discuss their child's participation in the intervention with the participant's primary care physician

Exclusion Criteria:
  • Adolescents with unstable cardiac, pulmonary, endocrine or renal disorders

  • Adolescents with previous injuries or other conditions that may impact the safety of a running intervention

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Richard Dopp, MD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Richard Dopp, Associate Professor of Psychiatry, University of Michigan
ClinicalTrials.gov Identifier:
NCT05837351
Other Study ID Numbers:
  • HUM00212052
First Posted:
May 1, 2023
Last Update Posted:
May 1, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Richard Dopp, Associate Professor of Psychiatry, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 1, 2023